Synapse - Helena Yu

Results (285)

A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers

Meeting Abstract

Riely, G. J.; Yu, H. A.; Stephens, D.; Pietanza, M. C.; Smith-Marrone, S.; Fiore, J. J.; Goldstein, M.; Sima, C. S.; Kris, M. G.; Ginsberg, M. S.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Response to crizotinib and cabozantinib in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping

Meeting Abstract

Paik, P. K.; Drilon, A. E.; Yu, H. A.; Krug, L. M.; Rekhtman, N.; Borsu, L.; Ginsberg, M. S.; Berger, M. F.; Ladanyi, M.; Rudin, C. M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer

Meeting Abstract

Oxnard, G. R.; Ramalingam, S. S.; Ahn, M. J.; Kim, S. W.; Yu, H. A.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Cantarini, M.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay

Meeting Abstract

Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping

Journal Article

Paik, P. K.; Drilon, A.; Fan, P. D.; Yu, H.; Rekhtman, N.; Ginsberg, M. S.; Borsu, L.; Schultz, N.; Berger, M. F.; Rudin, C. M.; more...
Cancer Discovery (2015)

Fulltext@MSK | Save

Phase I/II study of HSP90 inhibitor AUY922 and Erlotinib for EGFR-Mutant lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Journal Article

Johnson, M. L.; Yu, H. A.; Hart, E. M.; Weitner, B. B.; Rademaker, A. W.; Patel, J. D.; Kris, M. G.; Riely, G. J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas

Journal Article

Yu, H. A.; Sima, C. S.; Hellmann, M. D.; Naidoo, J.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
Cancer (2015)

Fulltext@MSK | Save

Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas

Journal Article

Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S.; Gainor, J.; Shaw, A.; Hames, M.; Iams, W.; Aston, J.; Lovly, C. M.; more...
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Modern Pathology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Helena Alexandra Yu

Results (285)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Journal Article

Journal Article

Journal Article

Journal Article

Meeting Abstract

Meeting Abstract